Treat a new peptide program as a clinical service line, not a new SKU. Define the purpose, prescriber, evaluation, sourcing, staffing, documentation, and launch plan.
Clinical governance reviewed by Armando A Falcon, MD (FL ME 84789) · Florida regulatory framework reviewed August 2026.
Treat a new peptide program as a new clinical service line — not as a new SKU. Before marketing or selling it, define the clinical purpose, responsible prescriber, patient-evaluation pathway, pharmacy/source, staffing model, documentation, monitoring, escalation, and implementation plan. Business opportunity can start the discussion; it should not replace clinical review.
Define the business objective; identify the exact therapy (substance, formulation, route, source) rather than “we want to add peptides”; review the clinical and pharmacy framework (evidence, safety, sourcing, prescribing, patient selection); build the operating model (who does what, documentation, medication handling, monitoring, escalation); review clinic fit (space, training, workflow, AHCA/insurance impact); then prepare for launch.
MFMD helps an existing brick-and-mortar practice evaluate and structure the clinical side of the business opportunity — service concept review, clinical feasibility, governance structure, prescribing and staffing model, pharmacy/sourcing considerations, documentation and escalation framework, implementation planning, and physician review before launch. This is clinical service-line development and business development, not AHCA licensure consulting.
Build the service line before you build the marketing campaign. See Add a Service Line to start.
Disclaimer — B2B clinical-governance & compliance education only. This content is general business, clinical-governance, and compliance information for healthcare practices. It does not create a physician-patient relationship, provide patient-specific medical advice or prescribing authority, or constitute legal advice. Requirements vary by ownership, services offered, provider credentials, payer model, facility type, and whether a practice is licensed or exempt — clinics remain responsible for independently verifying the current laws, rules, and professional requirements that apply to their structure and services before implementation.
Florida Statutes Chapter 458 — Medical Practice Act
Florida Statutes Chapter 465 — Pharmacy Act (compounding & dispensing)
FDA — compounding and the FDA: questions and answers
Peptide & Wellness — medical director services
All Florida medical-director resources
Medical director services across selected Central, South, and Gulf Coast Florida markets — Miami & Fort Lauderdale, Palm Beach County, Orlando, Tampa Bay, Sarasota & Bradenton, Fort Myers & Naples. See areas we serve. Clinic acceptance and physician availability are confirmed for each location.
Under the medical direction of Armando A Falcon, MD (FL ME 84789). Serving approved Central, South, and Gulf Coast Florida markets; clinic acceptance and physician availability confirmed individually. Call or WhatsApp +1 (305) 877-7507.